PRECISE-HBR Bleeding Risk Score
Please fill in the required fields (Age, Hemoglobin, eGFR, WBC) and click Calculate.
Score Components
| Risk Factor | Value | Score |
|---|---|---|
| Age (years) | 0 | |
| Hemoglobin (g/dL) |
g/dL
|
0 |
| eGFR (mL/min/1.73m²) | 0 | |
| White Blood Cell Count (×10³/µL) | 0 | |
| Previous Spontaneous Bleeding |
|
0 |
| Long-term Oral Anticoagulation |
|
0 |
|
ARC-HBR Factors ≥1
Thrombocytopenia, bleeding diathesis, active malignancy, liver cirrhosis, recent major surgery/trauma, chronic NSAIDs/corticosteroids |
|
0 |
| Base Score | 2 |
Bleeding vs. Thrombosis Tradeoff Analysis
Assess the individualized risk of BARC 3-5 bleeding vs. MI/stent thrombosis using the ARC-HBR tradeoff model.
High Bleeding Risk (HBR) Detected
Based on the PRECISE-HBR score (≥23), consider abbreviated DAPT or de-escalation strategies. Always consult with the treating physician before making changes to antiplatelet therapy.
ARC-HBR Guideline Reference
Citation
Title: Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention
Authors: Gragnano, Felice; van Klaveren, David; Heg, Dik; et al.
Journal: Circulation